Department of Otorhinolaryngology and Head and Neck Surgery, The Affiliated Lihuili Hospital, Ningbo University, 315040 Ningbo, Zhejiang, China.
Department of Biochemistry and Molecular Biology, Ningbo University School of Medical, 315211 Ningbo, Zhejiang, China.
Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1097-1105. doi: 10.52586/5012.
: Data for the global burden of laryngeal cancer (LC) are limited. : We reported the incidence of, disability-adjusted life years (DALYs), and deaths due to LC by age, sex and by social-demographic index (SDI) in all countries and territories during 2007 to 2017, based on data from the Global Burden of Disease (GBD) 2017 study. We also assessed the risk factors for LC-associated DALYs and deaths through a comparative risk assessment framework. : Globally, from 2007 to 2017, the age-standardized incidence rate increased by 0.95%, the age-standardized DALY rate decreased by 8.75%, and the age-standardized death rate decreased by 7.66%. The age-standardized incidence, DALY, and death rates in 2017 were all the highest in the low SDI quintile. The middle SDI quintile witnessed the highest percentage changes in age-standardized incidence, DALY, and death rates during 2007-2017. At the GBD regional level, the highest age-standardized incidence, DALY, and death rates in 2017 occurred in the Caribbean, followed by South Asia. East Asia showed the largest increases in age-standardized incidence, DALY, and death rates from 2007 to 2017. At the national level, China and Jamaica reported the largest percentage increases in the age-standardized incidence, DALY, and death rates over the study period. : The global age-standardized incidence of LC remain stable. However, the age-standardized DALY and death rates decreased significantly over the study period. Impact: Our findings will be beneficial for developing policies to reduce the disease burden of LC in particular regions or countries.
喉癌(LC)的全球负担数据有限。我们根据 2017 年全球疾病负担(GBD)研究的数据,报告了 2007 年至 2017 年期间所有国家和地区按年龄、残疾调整生命年(DALY)和 LC 死亡人数,按社会人口指数(SDI)划分。我们还通过比较风险评估框架评估了与 LC 相关的 DALY 和死亡的危险因素。
从 2007 年到 2017 年,全球年龄标准化发病率增长了 0.95%,年龄标准化 DALY 率下降了 8.75%,年龄标准化死亡率下降了 7.66%。2017 年低 SDI 五分位数的年龄标准化发病率、DALY 和死亡率均最高。2007-2017 年期间,中 SDI 五分位数的年龄标准化发病率、DALY 和死亡率的变化百分比最高。在 GBD 区域层面,2017 年年龄标准化发病率、DALY 和死亡率最高的是加勒比地区,其次是南亚。东亚 2007 年至 2017 年期间的年龄标准化发病率、DALY 和死亡率增长幅度最大。在国家层面上,中国和牙买加报告称,在研究期间年龄标准化发病率、DALY 和死亡率的百分比增幅最大。
全球 LC 的年龄标准化发病率保持稳定。然而,在研究期间,年龄标准化 DALY 和死亡率显著下降。
我们的研究结果将有助于制定政策,以减少特定地区或国家的 LC 疾病负担。